This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Darktrace Valuation
Is DRKT.Y undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6
Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of DRKT.Y when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: DRKT.Y ($7.73) is trading below our estimate of fair value ($9.11)
Significantly Below Fair Value: DRKT.Y is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for DRKT.Y?
Key metric: As DRKT.Y is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for DRKT.Y. This is calculated by dividing DRKT.Y's market cap by their current
earnings.
What is DRKT.Y's PE Ratio?
PE Ratio
44.8x
Earnings
US$110.90m
Market Cap
US$4.97b
DRKT.Y key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: DRKT.Y is expensive based on its Price-To-Earnings Ratio (44.8x) compared to the US Software industry average (38.7x).
Price to Earnings Ratio vs Fair Ratio
What is DRKT.Y's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
DRKT.Y PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
44.8x
Fair PE Ratio
30.5x
Price-To-Earnings vs Fair Ratio: DRKT.Y is expensive based on its Price-To-Earnings Ratio (44.8x) compared to the estimated Fair Price-To-Earnings Ratio (30.5x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.